Skip to main content
Premium Trial:

Request an Annual Quote

It's a Tough Day to Be Kari

After ages of speculation, Decode Genetics has finally declared bankruptcy -- and blogger Dan MacArthur is all over it. The company announced that it has filed for Chapter 11 bankruptcy in the US and also noted that it has entered into an agreement for a US investment firm to sell off a subsidiary that conducts most of the company's core business.

MacArthur adds, "While deCODE will limp on for a couple more years under this agreement, this is very much a temporary fix. The core problem for the company - figuring out how it can use its expertise and unique resources to generate an actual profit, rather than simply more Nature Genetics paper - remains."

Decode has a note to subscribers to the DecodeMe service, calling the latest events a "restructuring" and assuring customers these developments "will underpin our ability to continue to keep you in the forefront of understanding what the latest advances in genetics mean for you and your health." In a separate email to customers posted on MacArthur's blog, the company adds a few more details about the sale of its business unit.

The Wall Street Journal reports that the 13-year-old company never turned a profit, and notes that the company "said that in the event of a liquidation, any recovery for stockholders would be 'highly unlikely.'"

And if you're looking for background, GenomeWeb Daily News has a story that includes previous challenges Decode has faced.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.